Table V.
Correlation between serum CatS levels and clinical data in Group DM with a HbA1c level <9%.
| Clinical index | Mean ± SD | CatS
|
||
|---|---|---|---|---|
| R2 | Coefficient | P-value | ||
| Age (year) | 58.60±12.73 | 0.019 | 0.001 | 0.627 |
| Course (year) | 6.40±5.15 | 0.008 | −0.002 | 0.753 |
| SBP (mmHg) | 136.47±23.83 | 0.207 | 0.002 | 0.088 |
| DBP (mmHg) | 79.40±8.75 | 0.008 | 0.001 | 0.745 |
| BMI (kg/m2) | 23.24±2.54 | 0.032 | 0.007 | 0.523 |
| FPG (mmol/l) | 8.60±2.59 | 0.103 | 0.012 | 0.244 |
| Serum Cr (μmol/l) | 88.28±52.59 | 0.002 | −8.3E-005 | 0.874 |
| TCH (mmol/l) | 5.19±1.46 | 0.003 | 0.004 | 0.840 |
| TG (mmol/l) | 2.21±1.48 | 0.049 | 0.015 | 0.427 |
| VLDL (mmol/l) | 0.98±0.63 | 0.066 | 0.040 | 0.355 |
| HbA1c (%) | 7.79±0.99 | 0.082 | 0.028 | 0.302 |
| HOMA-IR | 1.50±0.69 | 0.004 | −0.009 | 0.820 |
CatS, cathepsin S; Group DM, patients with type 2 diabetes; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; FPG, fasting plasma glucose; Cr, creatinine; TCH, cholesterol; TG, triglyceride; VLDL, very low density lipoprotein; HbAlc, glycosylated hemoglobin; HOMA-IR, homeostatic model assesment index of insulin resistance.